Tirzepatide Subcutaneous Injection: What the Evidence Shows

What SURMOUNT-1 found, and why the route of administration matters

The SURMOUNT-1 trial recruited 2,539 adults with obesity but without type 2 diabetes. Participants received once-weekly subcutaneous tirzepatide at 5 mg, 10 mg or 15 mg, or placebo, alongside lifestyle guidance. At 72 weeks, those on the 15 mg dose had lost roughly 20–21% of body weight on average, a result that was, at the time, larger than any previously seen in a phase-3 obesity trial. The subcutaneous delivery route is central to those figures: our guide to injecting tirzepatide explains how absorbing the medicine steadily under the skin, rather than allowing it to spike rapidly into the bloodstream, underpins the once-weekly dosing schedule.

The medicine's dual mechanism is also tied to how it is given. Because tirzepatide activates both GIP and GLP-1 receptors, it works on appetite, satiety signalling and gastric emptying in a way that a single-receptor medicine cannot replicate. The NHS medicines page for tirzepatide explains this dual action in plain language and is a useful reference alongside the information your prescriber provides.

One practical point worth naming early: the 2.5 mg starting tirzepatide pen exists to let your body adjust to the medicine, not to produce significant weight loss. Expecting results at that stage is a common source of early frustration, and understanding why the titration schedule is structured that way makes it easier to stay with the programme.

Choosing your injection site and getting the technique right

Three sites are approved for tirzepatide subcutaneous injections: the abdomen (at least 5 cm from the navel), the front of the thigh, and the outer upper arm. Rotating the site each week (and rotating within a site) reduces the risk of lipodystrophy, a localised change in fatty tissue that can affect how medicine is absorbed if the same spot is used repeatedly.

Before injecting, the skin should be clean and dry. Many people use a dedicated alcohol swab, and if you want a reliable supply, sterile alcohol swabs are available separately for this purpose. Pinching a small fold of skin before inserting the needle is helpful for people with less subcutaneous fat at the chosen site, particularly on the thigh. The needle should go in at roughly a 90-degree angle for most people; lean injection angles are typically only needed for those with very little subcutaneous tissue.

For a detailed walkthrough of the full technique, our guide on how to inject tirzepatide covers the process from pen preparation to safe disposal. Needles are replaced for every injection; keeping a spare tirzepatide injection needle to hand means you are never caught short between orders. Used pens and needles require a sharps container, check with your local pharmacy or GP surgery about collection points.

Side effects associated with subcutaneous tirzepatide and when to seek help

The most commonly reported side effects in SURMOUNT-1 were gastrointestinal: nausea, vomiting, diarrhoea and constipation appeared most often in the days after a new or increased dose, then generally settled as the body adapted. The slow titration schedule exists partly for this reason, moving up a dose too quickly tends to make GI effects sharper. Injection-site reactions, headache and fatigue were also reported, though usually mild.

Two situations warrant prompt medical attention. First, any severe or persistent stomach pain that radiates to the back, with or without vomiting, should be assessed urgently, the MHRA's January 2026 Drug Safety Update identified acute pancreatitis as an infrequent but serious risk with GLP-1 class medicines. Second, signs of a serious allergic reaction (swelling, difficulty breathing, rapid heartbeat) need emergency care. If you experience something unexpected and want to check whether it has been reported by others taking tirzepatide, the MHRA Yellow Card scheme lets patients and healthcare professionals report suspected side effects and see what has already been flagged.

Women taking oral contraceptives should be aware that subcutaneous tirzepatide can reduce pill absorption during the first four weeks of treatment and for four weeks after each dose increase; a non-oral method of contraception is recommended during those windows. This is covered in more detail on the tirzepatide injection overview.

Private access and what the consultation involves

Tirzepatide is a prescription-only medicine. In the UK, the licensed eligibility criteria for private treatment are a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, obstructive sleep apnoea or prediabetes. BMI alone does not determine approval; the prescriber considers your full health picture, any contraindications and your current medications.

For context on what private treatment costs and what a legitimate price should include, the Mounjaro pricing page sets out the market landscape honestly. Eli Lilly raised UK list prices substantially from September 2025, and private prices vary by dose and provider; any quoted price for a prescription medicine ought to include clinical assessment and aftercare, not just the pen itself.

At nume, your consultation is reviewed the same day by a real prescriber, a GPhC-registered Independent Prescriber reads your answers personally. Orders placed before midday on a working day are dispatched the same day once approved, arriving by DPD the next working day in plain packaging. A quiet midweek order fits that schedule neatly; if you are planning around a bank holiday or a busy patch, it is worth checking the dispatch calendar on the FAQs page so your delivery lands when you expect it. Our clinical team and pharmacy are registered with the GPhC (premises registration 9012878, verifiable at the GPhC register), and aftercare support runs seven days a week.

If you are ready to find out whether subcutaneous tirzepatide is suitable for you, start your free consultation and a prescriber will review your details the same day.